MARKET

HSIC

HSIC

Henry Schein
NASDAQ

Real-time Quotes | Nasdaq Last Sale

76.74
-0.91
-1.17%
Pre Market: 76.74 0 0.00% 08:01 07/01 EDT
OPEN
76.83
PREV CLOSE
77.65
HIGH
77.73
LOW
76.00
VOLUME
996
TURNOVER
--
52 WEEK HIGH
92.68
52 WEEK LOW
70.25
MARKET CAP
10.59B
P/E (TTM)
16.69
1D
5D
1M
3M
1Y
5Y
Henry Schein (HSIC) Global Dental Arm Rebounds Amid Cost Woes
Henry Schein's (HSIC) widespread network and channel mix along with favorable long-term trends in the dental business look encouraging.
Zacks · 06/17 13:47
Here's Why Henry Schein (HSIC) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks · 06/17 13:40
Stifel Adjusts Henry Schein's Price Target to $80 From $90, Reiterates Hold Rating
MT Newswires · 06/17 08:45
Declining Stock and Solid Fundamentals: Is The Market Wrong About Henry Schein, Inc. (NASDAQ:HSIC)?
It is hard to get excited after looking at Henry Schein's (NASDAQ:HSIC) recent performance, when its stock has declined...
Simply Wall St. · 06/14 14:24
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022
Upgrades
Benzinga · 06/14 14:03
Baird Lowers Henry Schein to Neutral From Outperform, Price Target to $88 From $103
MT Newswires · 06/14 05:06
Maureen Knott Named President of the Henry Schein Cares Foundation
MELVILLE, N.Y., June 13, 2022--Maureen Knott Named President of the Henry Schein Cares Foundation
Business Wire · 06/13 10:31
Henry Schein (HSIC) Inks New Deal to Acquire Condor Dental
Henry Schein's (HSIC) acquisition of a Switzerland-based dental distribution company will strengthen its presence in the attractive European market.
Zacks · 06/08 15:34
More
No Data
Learn about the latest financial forecast of HSIC. Analyze the recent business situations of Henry Schein through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 15 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

6.67%Strong Buy
20.00%Buy
53.33%Hold
20.00%Under-perform
0.00%Sell
Analyst Price Target
The average HSIC stock price target is 88.45 with a high estimate of 102.00 and a low estimate of 72.00.
High102.00
Average88.45
Low72.00
Current 76.82
EPS
Actual
Estimate
0.330.650.971.30
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 851
Institutional Holdings: 146.48M
% Owned: 106.10%
Shares Outstanding: 138.05M
TypeInstitutionsShares
Increased
193
8.82M
New
88
1.96M
Decreased
187
8.25M
Sold Out
47
2.30M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.46%
Healthcare Equipment & Supplies
+1.26%
Key Executives
Chairman/Director/Chief Executive Officer
Stanley Bergman
President/Vice Chairman/Director
James Breslawski
Chief Financial Officer/Senior Vice President
Ronald South
Corporate Executive
Andrea Albertini
Corporate Executive
David Brous
Corporate Executive
Brad Connett
Corporate Executive
Rene Willi
Chief Human Resource Officer/Senior Vice President
Lorelei Mcglynn
Executive Vice President/Chief Administrative Officer/Director
Gerald Benjamin
Executive Vice President/Director
Mark Mlotek
Senior Vice President/Chief Technology Officer
Christopher Pendergast
Senior Vice President/General Counsel
Kelly Murphy
Senior Vice President/Secretary
Michael Ettinger
Senior Vice President
James Mullins
Senior Vice President
Michael Racioppi
Senior Vice President
Walter Siegel
Other
Dirk Benson
Lead Director/Independent Director
Philip Laskawy
Director
Steven Paladino
Independent Director
Mohamad Ali
Independent Director
Deborah Derby
Independent Director
Joseph Herring
Independent Director
Kurt Kuehn
Independent Director
Anne Margulies
Independent Director
Carol Raphael
Independent Director
Elizabeth Rekow
Independent Director
Scott Serota
Independent Director
Bradley Sheares
Independent Director
Reed Tuckson
No Data
No Data
About HSIC
Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental and medical practitioners. The Company’s segments include Health care distribution and Technology and value-added services. The Health care distribution segment distributes consumable products, laboratory products, equipment repair services, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. Its global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions, medical practitioners and ambulatory surgery centers. The Technology and value-added services segments provides software, technology and other value-added services to health care practitioners. It also offers practice management software systems for dental and medical practitioners. The Company's value-added practice solutions include financial services on a non-recourse basis, e-services, practice technology, network and hardware services.

Webull offers kinds of Henry Schein, Inc. stock information, including NASDAQ:HSIC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HSIC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HSIC stock methods without spending real money on the virtual paper trading platform.